Covered when ANY of the following infant-specific clinical indications are present (infants < 12 months unless otherwise specified):
Covered indications: 1. Diagnosis of pertussis with positive cultures on discharge from acute care facility (monitor up to 1 month post diagnosis).
Covered indications: 2. Documented apnea accompanied by bradycardia to less than 80 beats per minute; monitor until the infant remains event free for 6 weeks.heart rate < 80 beats/min
Covered indications: 3. Documented apnea accompanied by marked hypotonia; monitor until the infant remains event free for 6 weeks.
Covered indications: 4. Documented apnea accompanied by oxygen desaturation (oxygen saturation below 90%), cyanosis or pallor; monitor until the infant remains event free for 6 weeks.SpO2 < 90%
Covered indications: 5. Documented gastro-esophageal reflux disease (GERD) that results in apnea, bradycardia, or oxygen desaturation; monitor until the infant remains event free for 6 weeks.
Covered indications: 6. Documented prolonged apnea greater than 20 seconds in duration; monitor until the infant remains event free for 6 weeks.apnea >= 20 seconds
Covered indications: 7. Infants with an apparent life‑threatening event (ALTE); monitor until the infant remains event free for 6 weeks.
ALTE defined as combination of apnea, color change, marked change in muscle tone, choking, or gagging.
Covered indications: 8. Apnea of prematurity (infant < 37 weeks gestational age): continued use is medically necessary until post‑conceptional age > 43 weeks and event free for 6 weeks.post‑conceptional age > 43 weeks
Post‑conceptional age = gestational age at birth plus age in weeks from birth.
Covered indications: 9. Infants with bradycardia while on caffeine, theophylline, or similar agents; monitor until event free for 6 weeks off medication.
Covered indications: 10. Infants with chronic lung disease/bronchopulmonary dysplasia, especially those requiring supplemental oxygen, CPAP, or mechanical ventilation (medical necessity).
Covered indications: 11. Infants with congenital myasthenic syndromes (medical necessity).
Covered indications: 12. Infants with neurologic or metabolic disorders affecting respiratory control (medical necessity reviewed on an individual case basis).
Covered indications: 13. Infants with tracheostomies or anatomic airway abnormalities that make them vulnerable to airway compromise (medical necessity reviewed on an individual case basis).
Covered indications: 14. Later siblings of infants who died of SIDS: monitor until they are 1 month older than the age at which the earlier sibling died and remain event free.